HDA Convenes Supply Chain Experts and Patient Advocates To Examine Drug Shortages Solutions

November 07, 2024

HDA recently hosted a LinkedIn Live discussion exploring how supply chain stakeholders are working together to tackle these challenges and advocate for solutions. The event featured perspectives from Laura Bray, Chief Change Maker and Founder of Angels for Change, and April Giles, Executive Director of the End Drug Shortages Alliance (EDSA). Chip Davis, HDA President and Chief Executive Officer, moderated the discussion, which also touched upon effects of recent hurricanes on the prescription supply and the newly announced Biden Cancer Moonshot pilot program to curb pediatric shortages.

Read three takeaways from the conversation.

Fostering Inclusion: A Spotlight on HDA’s Hispanic and Latin Employee Network

September 24, 2024

In honor of Hispanic Heritage Month (September 15‒October 15), we recognize the volunteer leaders of HDA’s Hispanic and Latin Employee Network (HLEN) employee resource group (ERG). HLEN ERG lead Victor H. Cuesta, MBA, Territory Manager, Miami for MWI Animal Health, Cencora, and assistant lead Anali Perez, Contract Coordinator for Sagent Pharmaceuticals, discuss their aspirations for this group and reasons for participating.

Faces of the Supply Chain: Distribution Sector Career Pathways

August 06, 2024

As some of the best minds in distribution convened for the 2024 Distribution Management Conference, HDA spoke with professionals at all stages of their careers to explore paths that led to them to rewarding work. Their insights are featured in the latest installment of the Faces of the Supply Chain video series.

In part two of our two-part series, we share some of the valuable perspectives on careers in distribution highlighted during these conversations.

Faces of the Supply Chain: Distribution Sector Problem Solving and Cold Chain Capabilities

August 06, 2024

In the latest installment of HDA’s Faces of the Supply Chain series, HDA asked industry leaders to reflect on the role of healthcare distribution sector professionals as they navigate everyday challenges and adapt to evolving best practices as novel treatments emerge.

In part one of our two-part blog series, HDA is recapping the valuable perspectives shared during our conversations conducted at the 2024 Distribution Management Conference.

Supply Chain Experts Discuss the Future of the U.S. Pharmaceutical Cold Chain

July 23, 2024

HDA hosted a LinkedIn Live event exploring the challenges, successes and future of the U.S. pharmaceutical cold chain. The event delved into key findings from the HDA Research Foundation’s report, The Future of the U.S. Pharmaceutical Cold Chain, and featured perspectives from Jeffrey Gainer, Business Process Senior Manager at McKesson, and Rena K. Goins, Executive Director of Global Trade and Distribution at Regeneron. HDA’s Perry Fri, EVP of Industry Relations and Member Services and COO of the HDA Research Foundation, moderated the discussion. Here are three takeaways from the discussion.

Discussing Solutions To Address Drug Shortages

July 08, 2024

HDA recently partnered with The Hill to facilitate an event, “Keeping Pharmacy Shelves Filled: Solutions to Address Drug Shortages,” which included speakers Rep. Larry Buschon, MD (R-Ind.); Heather Zenk, President of U.S. Supply Chain, Cencora; Dr. Mark McClellan, Director, Duke-Margolis Institute for Health Policy and Former FDA Commissioner; Michael Kleinrock, Lead Research Director, IQVIA Institute for Human Data Science; and Dr. Marta Wosińska, Senior Fellow, Center on Health Policy, The Brookings Institution. HDA President and CEO Chip Davis also sat down with Joe Ruffolo, SVP and General Manager at The Hill, to discuss how the healthcare distribution industry plays a vital role in mitigating the impact of drug shortages.